US Broker Ratings

Arvinas, Inc. (ARVN) Stock Analysis: Navigating the Biotech Frontier with Potential Upside

Arvinas, Inc. (NASDAQ: ARVN) is a clinical-stage biotechnology company that has carved a niche in the healthcare sector by focusing on innovative protein degradation therapies. Headquartered in New Haven, Connecticut,..

Personalis, Inc. (PSNL) Stock Analysis: Navigating Growth Challenges with Strategic Collaborations

Personalis, Inc. (NASDAQ: PSNL), a key player in the healthcare sector’s diagnostics and research industry, is at a critical juncture. With a market capitalization just shy of $1 billion, this..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Promising 315% Potential Upside in Biotechnology

Investors with a keen eye on the biotechnology sector may find Anavex Life Sciences Corp. (NASDAQ: AVXL) an intriguing prospect. Positioned in the healthcare industry, Anavex is making significant strides..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Exploring a 46% Potential Upside for Investors

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a dynamic player in the biotechnology sector, is capturing investor attention with its compelling 46.42% potential upside, as suggested by current analyst ratings. Headquartered..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: A Biotech with 90% Upside Potential

Day One Biopharmaceuticals, Inc (NASDAQ: DAWN) is making waves in the biotechnology sector with a compelling growth narrative. As a commercial-stage company, Day One is dedicated to developing innovative treatments..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating the -3.73% Potential Downside in a Competitive Medical Device Landscape

Investors with an eye on the healthcare sector, particularly those focused on medical devices, might find Standard BioTools Inc. (NASDAQ: LAB) an intriguing subject of analysis. With a market capitalization..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 112.50% Potential Upside in the Healthcare Sector

Organogenesis Holdings Inc. (NASDAQ: ORGO), a notable player in the regenerative medicine landscape, is capturing investor attention with a striking potential upside of 112.50%. As the company navigates the complex..

COMPASS Pathways Plc (CMPS) Stock Analysis: Exploring a 135.88% Potential Upside in Mental Health Innovation

COMPASS Pathways Plc (NASDAQ: CMPS) is currently capturing the attention of investors with its promising advancements in mental health treatments and an intriguing potential upside of 135.88%. As a biotechnology..

Verastem, Inc. (VSTM) Stock Analysis: Exploring a 141% Potential Upside in the Promising Biotech Sector

Verastem, Inc. (NASDAQ: VSTM), a U.S.-based biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to cancer treatment. As a development-stage company, Verastem focuses on creating..

Gyre Therapeutics, Inc. (GYRE) Investor Outlook: A Potential 123% Upside in the Biotech Space

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a pioneering biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to tackling organ fibrosis through small-molecule drugs. Situated in the..

MBX Biosciences, Inc. (MBX) Stock Analysis: Exploring a Potential 42.85% Upside in Biotech Innovation

MBX Biosciences, Inc. (MBX), a clinical-stage biopharmaceutical company specializing in precision peptide therapies, is garnering significant attention from investors due to its promising pipeline and potential market advancements. With a..

Neuropace, Inc. (NPCE) Stock Analysis: A 12.97% Potential Upside with Strong Buy Ratings

Neuropace, Inc. (NASDAQ: NPCE), a pioneering company in the medical device sector, is capturing investor attention with its innovative solutions in the treatment of drug-resistant focal epilepsy. Founded in 1997..

Kura Oncology, Inc. (KURA) Rating Update: 258% Potential Upside Highlights Growth Potential in Biotech Sector

Kura Oncology, Inc. (NASDAQ: KURA), a prominent player in the biotech sector, continues to capture investor attention with its promising pipeline of cancer therapies. Headquartered in San Diego, this clinical-stage..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring a Promising 111.93% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology firm, presents an exciting opportunity for investors in the healthcare sector with a remarkable potential upside of 111.93%. Specializing in the discovery..

EyePoint, Inc. (EYPT) Stock Analysis: Unpacking the 120.9% Potential Upside

EyePoint, Inc. (NASDAQ: EYPT), a dynamic player in the biotechnology sector, has captured investor attention with a promising 120.9% potential upside, according to analyst ratings. Specializing in therapeutics for serious..

Inventiva S.A. (IVA) Stock Analysis: Exploring a 108.61% Potential Upside with Strong Buy Ratings

Inventiva S.A. (IVA), a French biotechnology company listed on the American Depositary Receipt (ADR) market, is capturing investor attention with its promising pipeline and compelling analyst endorsements. With a current..

SIGA Technologies Inc. (SIGA): Valuation Insights and Growth Potential Amidst Healthcare Sector Challenges

Investors eyeing opportunities in the healthcare sector might find SIGA Technologies Inc. (NASDAQ: SIGA) an intriguing prospect. With a market capitalization of $481.94 million, this New York-based pharmaceutical company is..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Challenges with an 8.08% Upside Potential

Investors examining Cross Country Healthcare, Inc. (NASDAQ: CCRN) are evaluating a company deeply rooted in the healthcare sector, specifically within the medical care facilities industry. Based in Boca Raton, Florida,..

Replimune Group, Inc. (REPL) Stock Analysis: A 59% Potential Upside in Oncolytic Immunotherapy

Investors looking to tap into the burgeoning field of biotechnology may find Replimune Group, Inc. (REPL) an intriguing prospect. This clinical-stage company, with a market cap of $619.7 million, is..

Talkspace, Inc. (TALK) Investor Outlook: 25.94% Potential Upside and Strong Buy Ratings Highlight Growth Potential

Talkspace, Inc. (NASDAQ: TALK), a pioneering force in the virtual behavioral healthcare sector, is capturing the attention of investors thanks to its impressive potential upside and a strong lineup of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds